Production (Stage)
Journey Medical Corporation
DERM
$7.16
-$0.23-3.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.07M | 1.52M | -2.39M | -3.36M | -10.44M |
| Total Depreciation and Amortization | 1.09M | 912.00K | 837.00K | 839.00K | 836.00K |
| Total Amortization of Deferred Charges | 101.00K | 94.00K | 87.00K | 64.00K | 62.00K |
| Total Other Non-Cash Items | 1.52M | 1.16M | 1.19M | 1.82M | 1.41M |
| Change in Net Operating Assets | -1.46M | -1.46M | -877.00K | -4.54M | 3.11M |
| Cash from Operations | -2.83M | 2.23M | -1.16M | -5.18M | -5.02M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -15.00M | -- | -- | -- |
| Cash from Investing | -- | -15.00M | -- | -- | -- |
| Total Debt Issued | -- | 5.05M | -50.00K | 5.00M | -- |
| Total Debt Repaid | -625.00K | -625.00K | -625.00K | -- | -- |
| Issuance of Common Stock | 4.22M | 6.24M | 381.00K | 31.00K | 1.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -50.00K | -- | -- | -- |
| Cash from Financing | 3.60M | 10.62M | -294.00K | 5.03M | 1.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 765.00K | -2.16M | -1.45M | -145.00K | -3.38M |